Acorda Therapeutics Inc., of Hawthorne, N.Y., appointed Steven Rauscher to its board.
Advanced Cell Technology Holdings Inc., of Worcester, Mass., appointed James Stewart chief financial officer.
Ambrx Inc., of San Diego, appointed Bruce Kimmel vice president of therapeutic applications.
Arbios Systems Inc., of Los Angeles, appointed Amy Factor interim CEO and a member of its board.
Barrier Therapeutics Inc., of Princeton, N.J., appointed Michael Laferrera vice president of marketing and commercial planning, Steve Miller vice president of sales, and Marshall Rizzo global head supply chain and trade relations.
Biosyntrx, of Denver, appointed Burton Goldberg to its scientific advisory board.
BrainStorm Cell Therapeutics Inc., of Tel Aviv, Israel, appointed Jeffrey Kordower to its scientific advisory board, and Robert Shorr to its board.
Callisto Pharmaceuticals Inc., of New York, appointed Pamela Harris chief medical officer.
Cellegy Pharmaceuticals Inc., of South San Francisco, appointed Robert Caso vice president of finance and chief financial officer.
CeMines Inc., of Golden, Colo., appointed Gary Carter vice president of corporate development.
Compugen Ltd., of Tel Aviv, Israel, appointed Eran Aharonson vice president, computational life science research and development.
Cytomedix Inc., of Rockville, Md., appointed Ronald Baker vice president for sales and marketing.
Dendritic NanoTechnologies Inc., of Mount Pleasant, Mich., appointed Michael Pirc to its board.
Discovery Partners International Inc., of San Diego, appointed Michael Venuti chief scientific officer.
Dyadic International Inc., of Jupiter, Fla., appointed Robert Shapiro independent director.
Galapagos Genomics NV, of Mechelen, Belgium, appointed Staf Van Reet vice president of corporate development.
Generex Biotechnology Corp., of Toronto, appointed Mindy Allport-Settle and Peter Amanatides to its regulatory compliance committee.
Genetics Squared Inc., of Ann Arbor, Mich., appointed Franco Muggia and Anthony Tolcher to its scientific advisory board.
GenPat77, of Berlin, appointed Metin Colpan to its supervisory board.
HaptoGuard Inc., of Fort Lee, N.J., appointed Malcolm MacNab vice president of clinical development.
Icoria Inc., of Research Triangle Park, N.C., appointed Keith Davis and Doug Morton to help facilitate the company's realignment, overseeing agricultural commitments and the health care business, respectively. The company also named Brett Farabaugh vice president of finance.
Imagenetix Inc., of San Diego, formed a scientific and medical advisory board to include Jonathan Adachi, Dan Gallaher and Robert Beeten.
ImmuneRegen Biosciences, of Scottsdale, Ariz., appointed Martina Cartwright associate adviser to its bioterrorism preparedness advisory board.
IntegraGen, of Paris, appointed Gerald Wagner nonexecutive director.
Inyx Inc., of New York, appointed John Hamerski vice president and chief financial officer, and Josette Wys vice president business development.